The drug, which works by blocking the reuptake of norepinephrine and dopamine, increases activity in the brain, including ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The case focused on whether the Mexican government could sue U.S. manufacturers over claims that they shared blame for ...

Congressman Dave Taylor (OH-02) and Congresswoman Jan Schakowsky (IL-09) today introduced the bipartisan Drug-price ...

Correspondence to Dr Wouter B Nagengast, Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen 9700 RB, Netherlands; w.b.nagengast{at}umcg.nl Objective ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...